logo-loader

MagicMed completes patent portfolio of their Psybrary while launching candidate selection program

Published: 11:29 22 Dec 2020 EST

MagicMed Industries CEO Dr. Joseph Tucker joined Steve Darling from Proactive with news the company completed the development of their psilocybin-derivatives patent portfolio which they call “The Psybrary”

Tucker says the Psybrary is a collection of novel psychedelic-derivative drug candidates, manufacturing methods, and pharmacological.

Tucker also told Proactive thew company has filed 12 patent applications directed to 9 different chemical compound categories covering over 125 million individual molecules.

MagicMed and Proactive Present Magic Moments Videocast on AI in Psychedelics

Dr. Joseph Tucker, CEO of MagicMed and Steve Darling, Senior Broadcaster from Proactive talk about the use of Artificial Intelligence in the Psychedelpics sector with special guests Richard Dallaway, Founder of April19, and Roshan Bhave, Senior Data Scientist for Cognistx.

on 18/3/21